Cite
MOESM2 of Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay
MLA
Silver, Nicholas, et al. MOESM2 of Characterization of Minority HIV-1 Drug Resistant Variants in the United Kingdom Following the Verification of a Deep Sequencing-Based HIV-1 Genotyping and Tropism Assay. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........91b2d3612410b35512628637467edbe6&authtype=sso&custid=ns315887. Accessed 24 Sept. 2024.
APA
Silver, N., Paynter, M., McAllister, G., Atchley, M., Sayir, C., Short, J., Winner, D., Alouani, D., Sharkey, F., Bergefall, K., Templeton, K., Carrington, D., & QuiĂąones-Mateu, M. (n.d.). MOESM2 of Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
Chicago
Silver, Nicholas, Mary Paynter, Georgina McAllister, Maureen Atchley, Christine Sayir, John Short, Dane Winner, et al. 2024. “MOESM2 of Characterization of Minority HIV-1 Drug Resistant Variants in the United Kingdom Following the Verification of a Deep Sequencing-Based HIV-1 Genotyping and Tropism Assay.” Accessed September 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........91b2d3612410b35512628637467edbe6&authtype=sso&custid=ns315887.